2020

1. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

   Blood, Vol. 135, Núm. 26, pp. 2375-2387

2. Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

   Blood Cancer Journal, Vol. 10, Núm. 10